Compare Incyte Corporation (INCY) vs Monolithic Power Systems Inc (MPWR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs Monolithic Power Systems Inc — how do they compare? Incyte Corporation trades at $112.79 (market cap $22.85B), while Monolithic Power Systems Inc trades at $1,386.29 (market cap $67.32B). The key difference: Monolithic Power Systems Inc is far larger — about 2.9× Incyte Corporation's market cap, and Monolithic Power Systems Inc pays a 0.58% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Incyte Corporation for 33 Days and Monolithic Power Systems Inc for 25 Days on average.
| INCY | MPWR | |
|---|---|---|
Market Cap | $22.85B | $67.32B |
Volume | 1,927,029 | 826,960 |
Sector | Health | Technology |
52-Week High | $129.93 | $1.69K |
52-Week Low | $83.80 | $856.96 |
Typical Hold Time | 33 Days | 25 Days |
Enterprise Value | $18.35B | $65.92B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Incyte (INCY) trades at $112.75, down 0.61% today, with a bearish technical signal but strong fundamentals. The stock shows robust profitability with a 27.71% net income margin and 30.67% ROE. Recent news includes FDA approval for Atebrioz and expansion of its inflammation portfolio, supporting growth beyond its key drug JAKAFI. Revenue grew to $5.14 billion in 2025, with net income surging to $1.29 billion, reflecting improved operational efficiency.
The outlook is positive with a consensus price target of $132.43, implying 17% upside, though near-term earnings pressure and JAKAFI's patent expiry after 2029 pose risks. Analyst sentiment is bullish (52% buy ratings), but technical indicators suggest caution with key support at $111. Execution on pipeline diversification remains critical for sustained growth.
MPWR trades at $1,369.80, down 3.94% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with Q2 2026 EPS beating estimates at $6.50 versus $5.87 expected, and revenue growth from $2.79B in 2025 to $3.3B projected for 2026. Recent developments include a manufacturing partnership with GlobalFoundries announced September 9, 2026, to scale power solutions for AI and data centers.
The outlook remains positive with 88% analyst buy ratings and a consensus price target of $1,830 representing 33.6% upside. Key risks include the premium valuation (P/E of 83.58) and potential margin pressure from increased competition. The stock's performance is closely tied to AI infrastructure demand growth and execution on new product launches.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About Monolithic Power Systems Inc
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →
